ES3025005T3 - Device for treating anaphylaxis - Google Patents

Device for treating anaphylaxis Download PDF

Info

Publication number
ES3025005T3
ES3025005T3 ES22716648T ES22716648T ES3025005T3 ES 3025005 T3 ES3025005 T3 ES 3025005T3 ES 22716648 T ES22716648 T ES 22716648T ES 22716648 T ES22716648 T ES 22716648T ES 3025005 T3 ES3025005 T3 ES 3025005T3
Authority
ES
Spain
Prior art keywords
epinephrine
formulation
metered dose
dose inhaler
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES22716648T
Other languages
English (en)
Spanish (es)
Inventor
George Harry Luciuk
Andrew Robert Martin
Conor Aidan Ruzycki
Warren Hugh Finlay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kokua Pharma Inc
Original Assignee
Kokua Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kokua Pharma Inc filed Critical Kokua Pharma Inc
Application granted granted Critical
Publication of ES3025005T3 publication Critical patent/ES3025005T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A61M11/003—Particle size control by passing the aerosol trough sieves or filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C19/00—Acyclic saturated compounds containing halogen atoms
    • C07C19/08—Acyclic saturated compounds containing halogen atoms containing fluorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2209/00—Ancillary equipment
    • A61M2209/02—Equipment for testing the apparatus

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Surgical Instruments (AREA)
  • Non-Portable Lighting Devices Or Systems Thereof (AREA)
  • Processing Of Meat And Fish (AREA)
ES22716648T 2021-03-23 2022-03-23 Device for treating anaphylaxis Active ES3025005T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163165102P 2021-03-23 2021-03-23
PCT/US2022/021612 WO2022204328A1 (en) 2021-03-23 2022-03-23 Device for treating anaphylaxis

Publications (1)

Publication Number Publication Date
ES3025005T3 true ES3025005T3 (en) 2025-06-05

Family

ID=81307871

Family Applications (1)

Application Number Title Priority Date Filing Date
ES22716648T Active ES3025005T3 (en) 2021-03-23 2022-03-23 Device for treating anaphylaxis

Country Status (18)

Country Link
US (1) US20220331237A1 (enrdf_load_stackoverflow)
EP (2) EP4188332B1 (enrdf_load_stackoverflow)
JP (1) JP2024515446A (enrdf_load_stackoverflow)
KR (1) KR20230165764A (enrdf_load_stackoverflow)
CN (1) CN117083054A (enrdf_load_stackoverflow)
AU (1) AU2022245300A1 (enrdf_load_stackoverflow)
BR (1) BR112023019156A2 (enrdf_load_stackoverflow)
CA (1) CA3212189A1 (enrdf_load_stackoverflow)
DK (1) DK4188332T3 (enrdf_load_stackoverflow)
ES (1) ES3025005T3 (enrdf_load_stackoverflow)
FI (1) FI4188332T3 (enrdf_load_stackoverflow)
HR (1) HRP20250566T1 (enrdf_load_stackoverflow)
IL (1) IL305534A (enrdf_load_stackoverflow)
LT (1) LT4188332T (enrdf_load_stackoverflow)
PT (1) PT4188332T (enrdf_load_stackoverflow)
RS (1) RS66787B1 (enrdf_load_stackoverflow)
SI (1) SI4188332T1 (enrdf_load_stackoverflow)
WO (1) WO2022204328A1 (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025072756A1 (en) * 2023-09-28 2025-04-03 Kokua Pharma Inc. Device, methods, and uses for treating acute allergic reactions
WO2025170986A1 (en) * 2024-02-06 2025-08-14 Kindeva Drug Delivery L.P. Drug delivery device

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9324250D0 (en) * 1993-11-25 1994-01-12 Minnesota Mining & Mfg Inhaler
EP1321159A1 (en) 2001-12-21 2003-06-25 CHIESI FARMACEUTICI S.p.A. Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices
ES2867378T3 (es) * 2002-06-28 2021-10-20 Civitas Therapeutics Inc Epinefrina inhalable
WO2004112702A2 (en) * 2003-06-13 2004-12-29 Advanced Inhalation Research, Inc. Low dose pharmaceutical powders for inhalation
CN101175479A (zh) * 2005-03-16 2008-05-07 霍尼韦尔国际公司 药物递送制剂、装置和方法
US8367734B1 (en) 2005-08-11 2013-02-05 Amphastar Pharmaceuticals Inc. Stable epinephrine suspension formulation with high inhalation delivery efficiency
GB0801876D0 (en) * 2008-02-01 2008-03-12 Vectura Group Plc Suspension formulations
SG189892A1 (en) * 2010-10-12 2013-06-28 Ivax Pharmaceuticals Ireland Nasal spray device
US20120204871A1 (en) * 2011-02-10 2012-08-16 Julio Cesar Vega Stable, non-corrosive formulations for pressurized metered dose inhalers
IN2015DN01597A (enrdf_load_stackoverflow) * 2012-08-29 2015-07-03 Chiesi Farma Spa
US10039710B2 (en) * 2015-09-18 2018-08-07 Insys Development Company, Inc. Epinephrine spray formulations
US9717683B1 (en) * 2016-06-29 2017-08-01 Ep Pharma, Llc Low-temperature inhalation administration of cannabinoid entities

Also Published As

Publication number Publication date
FI4188332T3 (fi) 2025-05-06
US20220331237A1 (en) 2022-10-20
RS66787B1 (sr) 2025-06-30
HRP20250566T1 (hr) 2025-06-20
EP4545122A2 (en) 2025-04-30
CA3212189A1 (en) 2022-09-29
BR112023019156A2 (pt) 2023-10-17
PT4188332T (pt) 2025-04-17
EP4188332A1 (en) 2023-06-07
KR20230165764A (ko) 2023-12-05
EP4545122A3 (en) 2025-05-07
LT4188332T (lt) 2025-05-12
SI4188332T1 (sl) 2025-07-31
EP4188332B1 (en) 2025-02-12
AU2022245300A1 (en) 2023-09-14
DK4188332T3 (da) 2025-05-05
IL305534A (en) 2023-10-01
JP2024515446A (ja) 2024-04-10
CN117083054A (zh) 2023-11-17
WO2022204328A1 (en) 2022-09-29

Similar Documents

Publication Publication Date Title
ES2779273T3 (es) Formulación superfina de formoterol
ES3025005T3 (en) Device for treating anaphylaxis
ES2358293T3 (es) Formulaciones de aerosol de diisobutirilapomorfina.
ES2464520T3 (es) Formulación en aerosol para EPOC
AU2006329199B2 (en) Treatment of respiratory diseases
BRPI0707235A2 (pt) formulação de fentanil sublingual, dose unitária de uma formulação de fentanil sublingual, métodos para tratar dor e para tratar a manifestação súbita da dor, dispositivos de dose unitária ou dose dupla e de dose múltipla para a administração sublingual de um medicamento, método para preparar uma composição farmacêutica para a administração sublingual, formulação farmacêutica sublingual, dose unitária de uma formulação farmacêutica sublingual, e, método para tratar um paciente humano
ME02342B (me) Farmaceutske formulacije rastvora za izmjerene doze inhalatora pod pritiskom
CN103052378A (zh) 包含磷酸二酯酶抑制剂的药物制剂
Chang et al. Cough as an adverse effect on inhalation pharmaceutical products
ES2983201T3 (es) Composiciones, métodos y sistemas para la administración de fármacos en aerosol
TW201249442A (en) Administration of iloprost as aerosol bolus
ES2533535T3 (es) Soluciones para inhalación
ES2886529T3 (es) Formulaciones de levodopa para el alivio rápido de la enfermedad de Parkinson
JP2018016658A (ja) 新規噴射剤含有チオトロピウム製剤
BR112012015335B1 (pt) formulação de aerossol para doença pulmonar obstrutiva crõnica
Dongare et al. An overview of recently published patents on pulmonary drug delivery devices
US20160151275A1 (en) Method and devices for manufacturing and delivering of aerosolized formulations
WO2025072756A1 (en) Device, methods, and uses for treating acute allergic reactions
WO2021188809A1 (en) Inhalable formulation of a solution containing levalbuterol tartrate
ES2232769T3 (es) Composicion farmaceutica que comprende salmeterol y budesonida para el tratamiento de trastornos respiratorios.
BR112020015646A2 (pt) Formulações intranasais de epinefrina e métodos para o tratamento de doença
Gad Safety assessment of therapeutic agents administered by the respiratory route
Sheth Theoretical and experimental behavior of suspension pressurized metered dose inhalers
JP2024533453A (ja) 送達デバイスおよび組成物
Myrdal et al. Pulmonary Delivery of Drugs by Inhalation